RxDoctor Payments Data

Jeanne Pierce, PA

Physician Assistant · Troutman, NCNPI 1144260233

Payments from drug & device makers

$2,024in general payments, 2019–2025

Across 108 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$404
  • GSK$255
  • AstraZeneca$202
  • AbbVie$191
  • Johnson & Johnson$174
  • Lilly USA, LLC$162
  • plus $635 from 13 others

What the payments were for

  • Food & beverage$1,92495%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,024 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$60,146
Medicare patients
141
Services billed
1,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$13,184
OzempicSemaglutide11$10,331
Spiriva RespimatTiotropium Bromide19$9,860
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,830
MyrbetriqMirabegron12$9,072
ArexvyRsvpref3 Antigen/As01e/Pf12$3,811
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,497
ShingrixVaricella-Zoster Ge/As01b/Pf11$2,482
Omeprazole98$2,160
Omega-3 Acid Ethyl Esters16$1,178
Atorvastatin Calcium114$1,120
Levothyroxine Sodium102$969
Gabapentin50$804
Rosuvastatin Calcium87$748
Lisinopril88$645

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$13$23,04531 claims
GSKTrelegy Ellipta, Arexvy, Shingrix$255$16,12336 claims
Novo NordiskOzempic$404$10,33111 claims
Astellas Pharma US IncMyrbetriq$57$9,07212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Troutman

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →